Recurrent Acute Biphenotypic Leukemia Withdrawn Phase 1 Trials for Rivogenlecleucel (DB19107)
Also known as: Acute, recurrent Biphenotypic Leukemia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0106027 (Recurrent Acute Biphenotypic Leukemia) | Withdrawn | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03807063 | Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant | Treatment |